CereGate Therapy for Freezing of Gait in PD
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify that you need to stop taking your current medications. However, your medication regimen must be stable for at least 28 days before starting the trial.
What data supports the effectiveness of the treatment CereGate Therapy for Freezing of Gait in Parkinson's Disease?
The research suggests that non-drug treatments like action observation and physical therapy can help manage freezing of gait in Parkinson's disease, which is often resistant to medication. This implies that CereGate Therapy, as a non-drug treatment, might also be effective in addressing this issue.12345
How is CereGate Therapy different from other treatments for freezing of gait in Parkinson's disease?
What is the purpose of this trial?
A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.
Research Team
Brian Blischak
Principal Investigator
CereGate Inc.
Eligibility Criteria
This trial is for Parkinson's Disease patients with Freezing of Gait who have an implanted Boston Scientific Gevia STN-DBS system and are on stable doses of Parkinson's medications. They must be adults between 21-75 years old, not severely cognitively impaired, and able to follow the study plan.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initiation
Participants begin CereGate therapy after assessment
Treatment
Participants use the CereGate software for 60 days on demand
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CereGate Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
CereGate Inc.
Lead Sponsor